ArticlePharmaceutics2022

In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention.

Tayo A Adekiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.